234 294

Cited 11 times in

Diagnostic Value of Circulating miR-202 in Early-Stage Breast Cancer in South Korea

DC Field Value Language
dc.contributor.author김승일-
dc.date.accessioned2020-09-29T05:02:25Z-
dc.date.available2020-09-29T05:02:25Z-
dc.date.issued2020-07-
dc.identifier.issn1010-660X-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/179536-
dc.description.abstractBackground and objectives: Breast cancer is the most common cancer among women worldwide. Early stage diagnosis is important for predicting increases in treatment success rates and decreases in patient mortality. Recently, circulating biomarkers such as circulating tumor cells, circulating tumor DNA, exosomes, and circulating microRNAs have been examined as blood-based markers for the diagnosis of breast cancer. Although miR-202 has been studied for its function or expression in breast cancer, its potential diagnostic value in a clinical setting remains elusive and miR-202 has not been investigated in South Korea. In this study, we aimed to evaluate the diagnostic utility of miR-202 in plasma samples of breast cancer patients in South Korea. Materials and Methods: We investigated miR-202 expression in the plasma of 30 breast cancer patients during diagnosis along with 30 healthy controls in South Korea by quantitative reverse transcription PCR. Results: The results showed that circulating miR-202 levels were significantly elevated in the breast cancer patients compared with those in healthy controls (p < 0.001). The sensitivity and specificity of circulating miR-202 were 90.0% and 93.0%, respectively. Additionally, circulating miR-202 showed high positivity at early stage. The positive rate of miR-202 was as follows: 100% (10/10) for stage I, 90% (9/10) for stage II, and 80% (8/10) for stage III. miR-202 was also a predictor of a 9.6-fold high risk for breast cancer (p < 0.001). Conclusions: Additional alternative molecular biomarkers for diagnosis and management of pre-cancer patients are needed. Circulating miR-202 might be potential diagnostic tool for detecting early stage breast cancer.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherMDPI-
dc.relation.isPartOfMEDICINA-LITHUANIA-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleDiagnostic Value of Circulating miR-202 in Early-Stage Breast Cancer in South Korea-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Surgery (외과학교실)-
dc.contributor.googleauthorJungho Kim-
dc.contributor.googleauthorSunyoung Park-
dc.contributor.googleauthorDasom Hwang-
dc.contributor.googleauthorSeung Il Kim-
dc.contributor.googleauthorHyeyoung Lee-
dc.identifier.doi10.3390/medicina56070340-
dc.contributor.localIdA00658-
dc.relation.journalcodeJ03886-
dc.identifier.eissn1648-9144-
dc.identifier.pmid32659906-
dc.subject.keywordRT-qPCR-
dc.subject.keywordbreast cancer-
dc.subject.keywordcirculating biomarker-
dc.subject.keyworddiagnosis-
dc.subject.keywordmiR-202-
dc.contributor.alternativeNameKim, Seung Il-
dc.contributor.affiliatedAuthor김승일-
dc.citation.volume56-
dc.citation.number7-
dc.citation.startPage340-
dc.identifier.bibliographicCitationMEDICINA-LITHUANIA, Vol.56(7) : 340, 2020-07-
dc.identifier.rimsid67148-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.